RxDoctor Payments Data

Matthew Gugliotti, MD

Family Medicine · New Middletown, OHNPI 1144456476

Payments from drug & device makers

$7,657in general payments, 2019–2025

Across 514 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$679
  • Pfizer$481
  • Amarin Pharma, Inc.$439
  • Novo Nordisk$425
  • AstraZeneca$373
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$7,61499%
  • Education$431%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)82$1,193
Amgen47$679
Pfizer32$481
Amarin Pharma, Inc.35$439
Novo Nordisk28$425
AstraZeneca22$373
Johnson & Johnson21$312
Teva Pharmaceuticals USA, Inc.23$309
Merck18$268
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$264
Bayer9$182
Biohaven Pharmaceutical Holding Company Ltd.10$163
Otsuka America Pharmaceutical, Inc.9$140
Biohaven Pharmaceuticals, Inc.11$131
Boehringer Ingelheim8$123
Abbott8$123
Novartis8$119
Kowa Pharmaceuticals America, Inc.7$113
Takeda Pharmaceuticals U.S.A., Inc.12$105
Esperion Therapeutics, Inc.6$103
Eisai Inc.6$101
Axsome Therapeutics, Inc.5$95
Nestle Healthcare Nutrition Inc.6$89
Jazz Pharmaceuticals Inc.4$76
Lilly USA, LLC5$75
Exact Sciences3$67
Sanofi-aventis U.S. LLC5$62
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$49
Shield Therapeutics Inc3$49
Romark Laboratories, LC4$47
Sumitomo Pharma America, Inc.3$46
Ironshore Pharmaceuticals Inc.3$45
GSK2$44
Corium, LLC3$44
IBSA Pharma Inc.3$43
Clarus Therapeutics Inc.3$43
Braeburn Inc.2$41
Genentech USA, Inc.3$41
Sanofi Pasteur Inc.2$36
Currax Pharmaceuticals LLC3$35
Astellas Pharma US Inc2$35
Tris Pharma Inc2$31
Dermira, Inc.2$31
Regeneron Healthcare Solutions, Inc.2$31
Seqirus USA Inc2$30
Upsher-smith Laboratories LLC2$30
Sunovion Pharmaceuticals Inc.2$27
E.r. Squibb & Sons, L.L.C.2$25
Corcept Therapeutics1$23
Neos Therapeutics, LP1$23
Avion Pharmaceuticals1$20
Xeris Pharmaceuticals, Inc.1$19
Orexo US, Inc.1$18
Idorsia Pharmaceuticals US Inc1$18
Biogen1$17
Lundbeck LLC1$17
Harmony Biosciences LLC1$16
Acella Pharmaceuticals, LLC1$16
Hikma Pharmaceuticals USA1$15
Azurity Pharmaceuticals, Inc.1$15

How this compares

$7,657 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$112,465
Medicare patients
275
Services billed
1,916

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban107$104,001
JanuviaSitagliptin Phosphate86$80,505
MounjaroTirzepatide36$45,285
OzempicSemaglutide28$41,991
ZenpepLipase/Protease/Amylase16$40,415
XareltoRivaroxaban46$39,555
TrulicityDulaglutide23$36,368
TradjentaLinagliptin38$30,442
FarxigaDapagliflozin Propanediol21$26,364
JardianceEmpagliflozin26$21,460
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$19,566
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$12,485
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl93$12,385
LinzessLinaclotide13$11,326
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,001

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$481$104,001107 claims
Lilly USA, LLCMounjaro, Trulicity$75$81,65359 claims
MerckJanuvia$268$80,50586 claims
Boehringer IngelheimTradjenta, Jardiance$123$51,90264 claims
Novo NordiskOzempic$425$41,99128 claims
Johnson & JohnsonXarelto$312$39,55546 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$373$37,58047 claims
GSKTrelegy Ellipta$44$19,56624 claims
AbbVieLinzess, Synthroid$1,193$16,944114 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone$15$12,38593 claims
Astellas Pharma US IncMyrbetriq$35$4,92211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in New Middletown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →